肝疾患診断の世界市場レポート 2025年

肝疾患診断の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は7.4%で、520億4,000万米ドルに成長します。予測期間中に予想される成長の原動力は、高齢者人口の増加、研究開発への支出の増加、生検手技数と関連疾患の増加、遠隔医療の広範な採用などの要因です。この期間に予想される主な動向には、個別化医療の台頭、診断キットの技術的進歩、迅速検査の革新、ヘルスケア技術の進歩、診断方法の改善などがあります。

アルコール消費量の増加が肝疾患診断市場の成長を牽引すると予想されます。アルコール消費は、社会規範の変化、より手頃な価格、広く入手可能、ストレスやメンタルヘルスの課題増加などにより増加しています。アルコール消費は肝臓の健康に影響を与えるため、脂肪肝、肝炎、肝硬変などの肝障害の兆候を早期に発見するための診断ツールが不可欠です。例えば、2022年12月の国民保健サービス（NHS）によると、アルコール消費量は年齢とともに増加し、16歳から24歳の個人の62％が過去12ヵ月間の消費を報告し、55歳から74歳の個人の85％がアルコール消費に従事しています。この動向は、肝臓の健康状態の早期発見とモニタリングの必要性が高まっていることから、肝疾患診断市場の成長に寄与しています。

肝疾患診断市場の企業は、肝臓の状態を評価するための革新的な非侵襲的ツールの開発に注力しています。これらのツールは、生検のような侵襲的な処置を必要とせず、正確で効率的な診断方法を提供します。例えば、2024年9月、インドの診断センターであるCity Imaging &Clinical社は、非アルコール性脂肪性肝疾患（NAFLD）やアルコール性肝疾患（ALD）などの肝疾患の早期発見を目的とした非侵襲的診断ツールであるFibroScanを発売しました。FibroScanはエラストグラフィ技術を用いて肝臓の硬さと脂肪含有量を迅速かつ正確に測定し、従来の生検に代わる非侵襲的な方法を提供します。手技はわずか5～15分で、プローブを肝臓に当て、音波を発して肝臓組織の硬さを評価し、線維症や瘢痕化などの状態の早期診断を可能にします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の肝疾患診断PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の肝疾患診断市場：成長率分析
• 世界の肝疾患診断市場の実績：規模と成長, 2019-2024
• 世界の肝疾患診断市場の予測：規模と成長, 2024-2029, 2034F
• 世界の肝疾患診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の肝疾患診断市場：診断技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 臨床検査
• 画像診断
• 内視鏡検査
• 生検
• その他の診断技術
• 世界の肝疾患診断市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非アルコール性脂肪性肝疾患
• 非アルコール性脂肪肝炎
• 線維症
• 肝硬変
• 肝細胞がん
• その他の病気
• 世界の肝疾患診断市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 研究所
• その他のエンドユーザー
• 世界の肝疾患診断市場、臨床検査の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液検査（肝機能検査、肝炎パネル）
• 酵素検査（ALT、AST、ALP）
• 遺伝子検査
• 血清学的検査
• 世界の肝疾患診断市場、イメージングのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 超音波画像診断
• CTスキャン
• MRI
• エラストグラフィー（FibroScan）
• 世界の肝疾患診断市場内視鏡検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 食道胃十二指腸鏡検査（EGD）
• カプセル内視鏡検査
• 世界の肝疾患診断市場、生検の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肝生検（針生検）
• 細針吸引生検
• 腹腔鏡下生検
• 世界の肝疾患診断市場、その他の診断技術の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 分子イメージング
• バイオマーカー検査
• 線維症スコアリングシステム

第7章 地域別・国別分析

• 世界の肝疾患診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の肝疾患診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 肝疾患診断市場：競合情勢
• 肝疾患診断市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Echosens SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boston Scientific Corporation
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• bioMerieux SA
• Genentech Inc.
• Perspectum Diagnostics Ltd.
• Owlstone Medical Ltd.
• Enterome SA
• Atlentis Therapeutics AG
• 89bio Inc.
• Aligos Therapeutics Inc.
• BioPredictive SAS
• Cosara Diagnostics Pvt. Ltd.
• Hepion Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 肝疾患診断市場2029：新たな機会を提供する国
• 肝疾患診断市場2029：新たな機会を提供するセグメント
• 肝疾患診断市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Liver disease diagnostics encompass the medical procedures and tests used to detect and evaluate a range of liver conditions, such as liver cirrhosis, hepatitis, fatty liver disease, and liver cancer. These diagnostic methods typically include blood tests to measure liver enzyme levels, imaging techniques such as ultrasound or CT scans, and occasionally biopsy procedures to collect tissue samples.

The primary diagnostic techniques for liver disease include laboratory tests, imaging, endoscopy, biopsy, and other methods. Laboratory tests involve analyzing blood and other samples to identify liver conditions. These tests are used to diagnose diseases such as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, fibrosis, cirrhosis, hepatocellular carcinoma, and more. They are utilized by a variety of end users, including hospitals, laboratories, and other healthcare settings.

The liver disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides liver disease diagnostics market statistics, including liver disease diagnostics industry global market size, regional shares, competitors with a liver disease diagnostics market share, detailed liver disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the liver disease diagnostics industry. This liver disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The liver disease diagnostics market size has grown strongly in recent years. It will grow from $36.26 billion in 2024 to $39.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historical period can be attributed to factors such as the rising prevalence of both acute and chronic liver conditions, an increase in liver diseases, higher alcohol consumption, growing awareness of liver health, and the expansion of healthcare infrastructure.

The liver disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $52.04 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The anticipated growth in the forecast period is driven by factors including the increasing geriatric population, higher spending on research and development, a rise in the number of biopsy procedures and related diseases, and the broader adoption of telemedicine. Key trends expected during this period include the rise of personalized medicine, technological advancements in diagnostic kits, innovations in rapid testing, progress in healthcare technologies, and improvements in diagnostic methods.

The rise in alcohol consumption is expected to drive the growth of the liver disease diagnostics market. Alcohol consumption has increased due to changing social norms, greater affordability, widespread availability, and rising stress or mental health challenges. As alcohol consumption impacts liver health, diagnostic tools are essential for detecting early signs of liver damage, such as fatty liver, hepatitis, or cirrhosis. For example, according to the National Health Service (NHS) in December 2022, alcohol consumption rose with age, with 62% of individuals aged 16 to 24 reporting consumption in the past 12 months, and 85% of individuals aged 55 to 74 engaging in alcohol consumption. This trend is contributing to the growth of the liver disease diagnostics market, as there is a greater need for early detection and monitoring of liver health.

Companies in the liver disease diagnostics market are focusing on the development of innovative, non-invasive tools to assess liver conditions. These tools provide accurate and efficient diagnostic methods without the need for invasive procedures such as biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, launched FibroScan, a non-invasive diagnostic tool aimed at the early detection of liver diseases such as non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). FibroScan uses elastography technology to measure liver stiffness and fat content quickly and accurately, offering a non-invasive alternative to traditional biopsies. The procedure takes only 5 to 15 minutes and involves placing a probe over the liver, which emits sound waves to assess liver tissue stiffness, enabling early diagnosis of conditions such as fibrosis or scarring.

In August 2024, Quest Diagnostics, a US-based medical laboratory company, acquired LifeLabs for $1 billion. This acquisition is expected to significantly enhance Quest Diagnostics' operational capabilities and expand its healthcare services in Canada. LifeLabs, a Canada-based laboratory company, specializes in liver disease diagnostics, particularly focusing on conditions such as non-alcoholic fatty liver disease (NAFLD), and the acquisition will help broaden Quest's diagnostic offerings in this area.

Major players in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMerieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, and Aiforia Technologies Plc.

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in liver disease diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the liver disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The liver disease diagnostics market consists of revenues earned by entities by providing services such as liver disease diagnostics, imaging studies, fibrosis assessment, viral hepatitis screening, and alcohol-related liver disease evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver disease diagnostics market also includes sales of blood test kits, imaging devices, and biopsy needles and instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Liver Disease Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liver disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for liver disease diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liver disease diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Diagnosis Technique: Laboratory Tests; Imaging; Endoscopy; Biopsy; Other Diagnosis Techniques
• 2) By Disease: Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Steatohepatitis; Fibrosis; Cirrhosis; Hepatocellular Carcinoma; Other Diseases
• 3) By End Users: Hospitals; Laboratories; Other End Users
• Subsegments:
• 1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel); Enzyme Tests (ALT, AST, ALP); Genetic Testing; Serological Tests
• 2) By Imaging: Ultrasound Imaging; CT Scans; MRI; Elastography (FibroScan)
• 3) By Endoscopy: Esophagogastroduodenoscopy (EGD); Capsule Endoscopy
• 4) By Biopsy: Liver Biopsy (Needle Biopsy); Fine Needle Aspiration Biopsy; Laparoscopic Biopsy
• 5) By Other Diagnosis Techniques: Molecular Imaging; Biomarker Testing; Fibrosis Scoring Systems
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Fujifilm Holdings Corporation; Echosens SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Liver Disease Diagnostics Market Characteristics

3. Liver Disease Diagnostics Market Trends And Strategies

4. Liver Disease Diagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Liver Disease Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Liver Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Liver Disease Diagnostics Market Growth Rate Analysis
• 5.4. Global Liver Disease Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Liver Disease Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Liver Disease Diagnostics Total Addressable Market (TAM)

6. Liver Disease Diagnostics Market Segmentation

• 6.1. Global Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Tests
• Imaging
• Endoscopy
• Biopsy
• Other Diagnosis Techniques
• 6.2. Global Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Alcoholic Fatty Liver Disease
• Non-Alcoholic Steatohepatitis
• Fibrosis
• Cirrhosis
• Hepatocellular Carcinoma
• Other Diseases
• 6.3. Global Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Laboratories
• Other End Users
• 6.4. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Laboratory Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests (Liver Function Tests, Hepatitis Panel)
• Enzyme Tests (ALT, AST, ALP)
• Genetic Testing
• Serological Tests
• 6.5. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Imaging, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ultrasound Imaging
• CT Scans
• MRI
• Elastography (FibroScan)
• 6.6. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Endoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Esophagogastroduodenoscopy (EGD)
• Capsule Endoscopy
• 6.7. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liver Biopsy (Needle Biopsy)
• Fine Needle Aspiration Biopsy
• Laparoscopic Biopsy
• 6.8. Global Liver Disease Diagnostics Market, Sub-Segmentation Of Other Diagnosis Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Molecular Imaging
• Biomarker Testing
• Fibrosis Scoring Systems

7. Liver Disease Diagnostics Market Regional And Country Analysis

• 7.1. Global Liver Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Liver Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liver Disease Diagnostics Market

• 8.1. Asia-Pacific Liver Disease Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liver Disease Diagnostics Market

• 9.1. China Liver Disease Diagnostics Market Overview
• 9.2. China Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liver Disease Diagnostics Market

• 10.1. India Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liver Disease Diagnostics Market

• 11.1. Japan Liver Disease Diagnostics Market Overview
• 11.2. Japan Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liver Disease Diagnostics Market

• 12.1. Australia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liver Disease Diagnostics Market

• 13.1. Indonesia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liver Disease Diagnostics Market

• 14.1. South Korea Liver Disease Diagnostics Market Overview
• 14.2. South Korea Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liver Disease Diagnostics Market

• 15.1. Western Europe Liver Disease Diagnostics Market Overview
• 15.2. Western Europe Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liver Disease Diagnostics Market

• 16.1. UK Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liver Disease Diagnostics Market

• 17.1. Germany Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liver Disease Diagnostics Market

• 18.1. France Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liver Disease Diagnostics Market

• 19.1. Italy Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liver Disease Diagnostics Market

• 20.1. Spain Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liver Disease Diagnostics Market

• 21.1. Eastern Europe Liver Disease Diagnostics Market Overview
• 21.2. Eastern Europe Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liver Disease Diagnostics Market

• 22.1. Russia Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liver Disease Diagnostics Market

• 23.1. North America Liver Disease Diagnostics Market Overview
• 23.2. North America Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liver Disease Diagnostics Market

• 24.1. USA Liver Disease Diagnostics Market Overview
• 24.2. USA Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liver Disease Diagnostics Market

• 25.1. Canada Liver Disease Diagnostics Market Overview
• 25.2. Canada Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liver Disease Diagnostics Market

• 26.1. South America Liver Disease Diagnostics Market Overview
• 26.2. South America Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liver Disease Diagnostics Market

• 27.1. Brazil Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liver Disease Diagnostics Market

• 28.1. Middle East Liver Disease Diagnostics Market Overview
• 28.2. Middle East Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liver Disease Diagnostics Market

• 29.1. Africa Liver Disease Diagnostics Market Overview
• 29.2. Africa Liver Disease Diagnostics Market, Segmentation By Diagnosis Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Liver Disease Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Liver Disease Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liver Disease Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Liver Disease Diagnostics Market Competitive Landscape
• 30.2. Liver Disease Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Echosens SA Overview, Products and Services, Strategy and Financial Analysis

31. Liver Disease Diagnostics Market Other Major And Innovative Companies

• 31.1. Boston Scientific Corporation
• 31.2. Laboratory Corporation of America Holdings
• 31.3. Quest Diagnostics Incorporated
• 31.4. Siemens Healthineers AG
• 31.5. bioMerieux SA
• 31.6. Genentech Inc.
• 31.7. Perspectum Diagnostics Ltd.
• 31.8. Owlstone Medical Ltd.
• 31.9. Enterome SA
• 31.10. Atlentis Therapeutics AG
• 31.11. 89bio Inc.
• 31.12. Aligos Therapeutics Inc.
• 31.13. BioPredictive SAS
• 31.14. Cosara Diagnostics Pvt. Ltd.
• 31.15. Hepion Pharmaceuticals Inc.

32. Global Liver Disease Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liver Disease Diagnostics Market

34. Recent Developments In The Liver Disease Diagnostics Market

35. Liver Disease Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Liver Disease Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Liver Disease Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Liver Disease Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer